In data supporting FDA approval, 48.1% implanted with Prodeon’s Urocross saw International Prostate Symptom Score improvements.

Prodeon Medical, a privately held medical device company focused on advancing minimally invasive therapies for urologic diseases, today announced it has received U.S. Food and Drug Administration (FDA ...

It may be possible to identify men who could benefit from earlier therapy. Researchers have developed a new blood test that can distinguish severely symptomatic BPH from BPH that occurs with few if ...

NASHVILLE, Tenn. (WKRN) — An enlarged prostate, known as Benign Prostatic Hyperplasia (BPH) and its symptoms may be an uncomfortable topic for people to discuss. Urologist Dr. Daniel Ramirez with ...

Previous studies may have overlooked the placebo effect. Botulinum toxin type A provides no clinical benefit for lower urinary tract symptoms (LUTS) or benign prostatic hyperplasia (BPH), a new review ...

Dr. Robyn Roberts of Urology Austin joined Studio 512 to talk about BPH, or Benign Prostatic Hyperplasia, which affects aging men. “An enlarged prostate – and the side effects that accompany it – is a ...

Benign prostatic hyperplasia (BPH) has traditionally been considered a single disease entity, but genomic studies revealed different gene-expression profiles in individuals with symptomatic and ...

Prostate enlargement, which is called Benign Prostatic Hyperplasia (BPH) is a non-cancerous enlargement and is common in ageing men. As the prostate enlarges, it compresses the urethra and interferes ...

CUMMING, Ga.--(BUSINESS WIRE)--PROCEPT BioRobotics Thursday (Sept. 5 th) announced that Northside Hospital Forsyth in partnership with Georgia Urology is the first in the world to offer Aquablation® ...

Dr. Varun Sundaram of Urology Austin spoke with Studio 512 Co-Host Rosie Newberry about benign prostatic hyperplasia, or BPH, which affects millions of men every year, as well as treatments including ...